Technical Analysis for AMED - Amedisys Inc

Grade Last Price % Change Price Change
grade A 184.33 4.34% 7.67
AMED closed up 4.34 percent on Monday, April 6, 2020, on 67 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Apr 28
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical AMED trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Overbought Stochastic Strength 0.00%
Fell Below 50 DMA Bearish 4.34%
MACD Bullish Centerline Cross Bullish 4.34%
NR7 Range Contraction 4.34%
Multiple of Ten Bearish Other 4.34%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Amedisys, Inc., together with its subsidiaries, operates as a home health and hospice company. It operates in two segments, Home Health and Hospice. The Home Health segment offers a range of services in the homes of individuals who may be recovering from an illness, injury, or surgical procedure. This segment provides skilled nursing, home health aides, physical and occupational therapy, speech therapy, and medical social services; and chronic care clinical programs for patients with chronic diseases, such as cardiovascular, respiratory, diabetes, behavioral health, rehabilitative, and medical surgical conditions. The Hospice segment offers care that is designed to offer comfort and support for those who are facing a terminal illness, including heart disease, pulmonary disease, dementia, Alzheimer's, HIV/AIDS, or cancer. As of December 31, 2012, the company owned and operated 435 Medicare-certified home health care centers, 97 Medicare-certified hospice care centers, and 2 hospice inpatient units in 38 states within the United States, the District of Columbia, and Puerto Rico. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.
Health Cancer Diabetes Medicare Caregiving Dementia HIV/Aids Alzheimer's Injury Hospice Occupational Therapy Chronic Diseases Heart Disease Palliative Care Speech Therapy Home Care Medical Social Services

Is AMED a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 202.76
52 Week Low 106.65
Average Volume 291,120
200-Day Moving Average 151.60
50-Day Moving Average 178.86
20-Day Moving Average 169.55
10-Day Moving Average 175.09
Average True Range 14.74
ADX 19.79
+DI 21.09
-DI 15.55
Chandelier Exit (Long, 3 ATRs ) 146.17
Chandelier Exit (Short, 3 ATRs ) 177.17
Upper Bollinger Band 192.98
Lower Bollinger Band 146.12
Percent B (%b) 0.82
BandWidth 27.63
MACD Line 1.05
MACD Signal Line -1.13
MACD Histogram 2.1781
Fundamentals Value
Market Cap 6.23 Billion
Num Shares 33.8 Million
EPS 1.17
Price-to-Earnings (P/E) Ratio 157.55
Price-to-Sales 1.15
Price-to-Book 3.39
PEG Ratio 1.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 195.54
Resistance 3 (R3) 195.01 190.75 193.67
Resistance 2 (R2) 190.75 187.89 191.01 193.05
Resistance 1 (R1) 187.54 186.13 189.14 188.07 192.43
Pivot Point 183.27 183.27 184.07 183.54 183.27
Support 1 (S1) 180.06 180.42 181.67 180.59 176.23
Support 2 (S2) 175.80 178.65 176.06 175.61
Support 3 (S3) 172.59 175.80 174.99
Support 4 (S4) 173.12